Australia Cardiovascular Monitoring and Diagnostic Devices Market Outlook to 2020

GlobalData
May 5, 2014
46 Pages - GLDATA18084
$2,500.00

Summary

GlobalData’s new report, "Australia Cardiovascular Monitoring and Diagnostic Devices Market Outlook to 2020", provides key market data on the Australia Cardiovascular Monitoring and Diagnostic Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems, Event Monitoring Systems and Holter Monitoring Systems.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiovascular Monitoring and Diagnostic Devices market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Cardiovascular Monitoring and Diagnostic Devices categories - Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems, Event Monitoring Systems and Holter Monitoring Systems.
- Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
- 2012 company shares and distribution shares data for the market category.
- Global corporate-level profiles of key companies operating within the Australia Cardiovascular Monitoring and Diagnostic Devices market.
- Key players covered include GE Healthcare, Philips Healthcare, Welch Allyn Inc., OSI Systems, Inc., CareFusion Corporation, Cardiac Science Corporation, Schiller AG and Card Guard Scientific Survival, Ltd.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.



Companies Mentioned

GE Healthcare
Philips Healthcare
Nihon Kohden Corporation
Fukuda Denshi Co., Ltd.
Schiller AG
Welch Allyn Inc.
OSI Systems, Inc.
Opto Circuits India Limited

'

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Cardiovascular Monitoring and Diagnostic Devices Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Cardiovascular Monitoring and Diagnostic Devices Market, Australia 8
3.1 Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Revenue ($m), 2005-2012 8
3.2 Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Revenue ($m), 2012-2020 10
3.3 Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Volume (Units), 2005-2012 12
3.4 Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Volume (Units), 2012-2020 14
3.5 Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Average Price ($), 2005-2020 16
3.6 Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Distribution Share by Revenue ($m), 2011-2012 18
3.7 Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Company Share by Revenue ($m), 2011-2012 19
4 Overview of Key Companies in Australia, Cardiovascular Monitoring and Diagnostic Devices Market 21
4.1 GE Healthcare 21
4.1.1 Company Overview 21
4.2 Philips Healthcare 21
4.2.1 Company Overview 21
4.3 Nihon Kohden Corporation 21
4.3.1 Company Overview 21
4.4 Fukuda Denshi Co., Ltd. 22
4.4.1 Company Overview 22
4.5 Schiller AG 22
4.5.1 Company Overview 22
4.6 Welch Allyn Inc. 22
4.6.1 Company Overview 22
4.7 OSI Systems, Inc. 23
4.7.1 Company Overview 23
4.8 Opto Circuits India Limited 23
4.8.1 Company Overview 23
5 Cardiovascular Monitoring and Diagnostic Devices Market Pipeline Products 24
6 Financial Deals Landscape 26
6.1 Equity Offerings 26
6.1.1 IM Medical Announces Private Placement Of Shares For US$0.2 Million 26
6.1.2 Allied Healthcare Completes Rights Offering Of Shares For US$15.6 Million 27
6.1.3 Uscom Completes Private Placement Of Shares For US$1 Million 29
6.1.4 Uscom Completes Private Placement Of Shares For US$0.03 Million 30
6.1.5 Compumedics Completes Public Offering Of Shares For US$0.24 Million 31
6.1.6 Allied Healthcare Completes Privates Placement Of Shares For US$2 Million 32
6.1.7 Allied Healthcare Completes Rights Issue Of Shares For US$3 Million 33
6.1.8 Uscom Announces Private Placement Of Shares For US$0.73 Million 34
7 Recent Developments 35
7.1 Corporate Communications 35
7.1.1 Sep 24, 2013: Uscom Ltd : New Global Sales Manager Appointed 35
7.2 Other Significant Developments 35
7.2.1 May 01, 2013: Uscom Appoints Grupo SIM As Distributor In Mexico 35
7.3 Product News 36
7.3.1 Apr 16, 2014: AtCor Medical Receives Patent in USA 36
7.3.2 Feb 24, 2014: Uscom BP+ new hypertension gold standard in children 36
7.3.3 Jul 15, 2013: AtCor Medical Receives European Patent 37
8 Appendix 38
8.1 Research Methodology 39
8.1.1 Coverage 39
8.1.2 Secondary Research 39
8.1.3 Primary Research 40
8.1.4 Market Modeling and Forecasting 41
8.1.5 Company Share Analysis 44
8.1.6 Distribution Share Analysis 45
8.2 Expert Panel 45
8.3 GlobalData Consulting 46
8.4 Contact Us 46
8.5 Disclaimer 46

1.1 List of Tables
Table 1: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2005-2012 9
Table 2: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2012-2020 11
Table 3: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Volume (Units), Historic, 2005-2012 13
Table 4: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Volume (Units), Forecast, 2012-2020 15
Table 5: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Average Price ($), Historic, 2005-2012 16
Table 6: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Average Price ($), Forecast, 2012-2020 17
Table 7: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 18
Table 8: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2011-2012 20
Table 9: Cardiovascular Monitoring and Diagnostic Devices Market Pipeline Products 24
Table 10: IM Medical Announces Private Placement Of Shares For US$0.2 Million 26
Table 11: Allied Healthcare Completes Rights Offering Of Shares For US$15.6 Million 27
Table 12: Uscom Completes Private Placement Of Shares For US$1 Million 29
Table 13: Uscom Completes Private Placement Of Shares For US$0.03 Million 30
Table 14: Compumedics Completes Public Offering Of Shares For US$0.24 Million 31
Table 15: Allied Healthcare Completes Privates Placement Of Shares For US$2 Million 32
Table 16: Allied Healthcare Completes Rights Issue Of Shares For US$3 Million 33
Table 17: Uscom Announces Private Placement Of Shares For US$0.73 Million 34
Table 18: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 41

1.2 List of Figures
Figure 1: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2005-2012 8
Figure 2: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2012-2020 10
Figure 3: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Volume (Units), Historic, 2005-2012 12
Figure 4: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Volume (Units), Forecast, 2012-2020 14
Figure 5: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Company Share (%), 2012 19
Figure 6: GlobalData Epidemiology-Based Forecasting Model 43
Figure 7: GlobalData Capital Equipment-Based Forecasting Model 44
Figure 8: Primary Interviews by Participant Type (%) 45

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Custom Research

Need a custom report
tailored to your goals and budget? 

E-mail us your project outline
or call Client Services to speak
with your industry analyst.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Discount Codes

Request Discount Codes
for reports of interest to you.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax